|
|
|
It is challenging for PET radiopharmaceuticals to be produced, synthesised, and delivered to a patient quickly. The demand for
68Ga-based tracers is increasing and technology in today's market does not meet the needs of clinical imaging centers.
|
|
|
| |
|
GE Healthcare offers you a solution with
Solid Target production on PET
cyclotrons to increase the availability to Gallium-68 based tracers to begin with.
You benefit from a fully integrated system with the PETtrace cooling and interlock
systems but also from:
| • |
A simplified radiochemistery workflow: one single FASTlab™ sequence
|
| • |
Wing-to-wing hardware: all you need is in this package
|
| • |
A one-stop shop: a comprehensive user training and service package
|
Want to discover more about PETtrace Solid Target Platform?
|
|
|
|
PETtrace Solid Target Platform brings you the reliability you can count on.
It also provides:
|
|
|
|
|
An automated process:
efficient workflows in just
a few mouse clicks
|
|
|
|
An easy-to-use system:
single-operator, cassette-
based plug and play
|
|
|
|
High performance:
Multi Curie production
with the flexibility for more applications
|
|
|
|
| |
|
Forget about the strain on the current supply chain of tracers. Choose the
PETtrace
Solid Target Platform integrated suite of technologies and
support. It ensures
a large supply of consistent, reliable, and cost-effective radiometal-based tracers.
|
|
|
| |
|
We are committed to offering
industry leading PET radiopharmacy solutions.
|
|
|
|
|
| |
|
|
